Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary Sweeney

Showing results (151-160 of 166) with videos related to

Pageof 17
Sort By:
Advanced Healthcare Materials|April 14, 2026
Extracellular Vesicles Modulation by an Adiponectin Receptor Agonist Provides Cardioprotection for Myocardial Ischemic InjuryJialing Tang, Wing Yan Chung, Serena M Pulente, et al.
American Journal of Physiology. Endocrinology and Metabolism|July 17, 2019
Tracking adiponectin biodistribution via fluorescence molecular tomography indicates increased vascular permeability after streptozotocin-induced diabetesNanyoung Yoon, Keith Dadson, Thanh Dang, et al.
Canadian Journal of Diabetes|February 7, 2014
The genetic and metabolic determinants of cardiovascular complications in type 2 diabetes: recent insights from animal models and clinical investigationsRita Kohen Avramoglu, Marc-André Laplante, Khai Le Quang, et al.
Clinical Endocrinology|April 16, 2008
Correlation of circulating full-length visfatin (PBEF/NAMPT) with metabolic parameters in subjects with and without diabetes: a cross-sectional studyRavi Retnakaran, Byung-Soo Youn, Ying Liu, et al.
Cell Metabolism|April 8, 2014
The furan fatty acid metabolite CMPF is elevated in diabetes and induces β cell dysfunctionKacey J Prentice, Lemieux Luu, Emma M Allister, et al.
American Journal of Physiology. Cell Physiology|December 25, 2023
The slow-release adiponectin analog ALY688-SR modifies early-stage disease development in the D2.<i>mdx</i> mouse model of Duchenne muscular dystrophyCatherine A Bellissimo, Shivam Gandhi, Laura N Castellani, et al.
Autophagy Reports|May 21, 2025
Impaired autophagy flux contributes to enhanced ischemia reperfusion injury in the diabetic heartJialing Tang, Nanyoung Yoon, Keith Dadson, et al.
American Journal of Physiology. Endocrinology and Metabolism|July 17, 2008
Adiponectin deficiency promotes endothelial activation and profoundly exacerbates sepsis-related mortalityHwee Teoh, Adrian Quan, K W Annie Bang, et al.
JCI Insight|January 6, 2026
IRP1 deficiency alters mitochondrial metabolism and protects against metabolic syndrome pathologiesWen Gu, Nicole Wilkinson, Carine Fillebeen, et al.
Atherosclerosis|June 21, 2020
Dietary sucrose induces metabolic inflammation and atherosclerotic cardiovascular diseases more than dietary fat in LDLr<sup>-/-</sup>ApoB<sup>100/100</sup> miceLaís R Perazza, Patricia L Mitchell, Benjamin A H Jensen, et al.
Pageof 17

Showing results (151-160 of 166) with videos related to

Sort By:
Pageof 17
Advanced Healthcare Materials|April 14, 2026
Extracellular Vesicles Modulation by an Adiponectin Receptor Agonist Provides Cardioprotection for Myocardial Ischemic InjuryJialing Tang, Wing Yan Chung, Serena M Pulente, et al.
American Journal of Physiology. Endocrinology and Metabolism|July 17, 2019
Tracking adiponectin biodistribution via fluorescence molecular tomography indicates increased vascular permeability after streptozotocin-induced diabetesNanyoung Yoon, Keith Dadson, Thanh Dang, et al.
Canadian Journal of Diabetes|February 7, 2014
The genetic and metabolic determinants of cardiovascular complications in type 2 diabetes: recent insights from animal models and clinical investigationsRita Kohen Avramoglu, Marc-André Laplante, Khai Le Quang, et al.
Clinical Endocrinology|April 16, 2008
Correlation of circulating full-length visfatin (PBEF/NAMPT) with metabolic parameters in subjects with and without diabetes: a cross-sectional studyRavi Retnakaran, Byung-Soo Youn, Ying Liu, et al.
Cell Metabolism|April 8, 2014
The furan fatty acid metabolite CMPF is elevated in diabetes and induces β cell dysfunctionKacey J Prentice, Lemieux Luu, Emma M Allister, et al.
American Journal of Physiology. Cell Physiology|December 25, 2023
The slow-release adiponectin analog ALY688-SR modifies early-stage disease development in the D2.<i>mdx</i> mouse model of Duchenne muscular dystrophyCatherine A Bellissimo, Shivam Gandhi, Laura N Castellani, et al.
Autophagy Reports|May 21, 2025
Impaired autophagy flux contributes to enhanced ischemia reperfusion injury in the diabetic heartJialing Tang, Nanyoung Yoon, Keith Dadson, et al.
American Journal of Physiology. Endocrinology and Metabolism|July 17, 2008
Adiponectin deficiency promotes endothelial activation and profoundly exacerbates sepsis-related mortalityHwee Teoh, Adrian Quan, K W Annie Bang, et al.
JCI Insight|January 6, 2026
IRP1 deficiency alters mitochondrial metabolism and protects against metabolic syndrome pathologiesWen Gu, Nicole Wilkinson, Carine Fillebeen, et al.
Atherosclerosis|June 21, 2020
Dietary sucrose induces metabolic inflammation and atherosclerotic cardiovascular diseases more than dietary fat in LDLr<sup>-/-</sup>ApoB<sup>100/100</sup> miceLaís R Perazza, Patricia L Mitchell, Benjamin A H Jensen, et al.
Pageof 17